Medicare (CMS) April 29th 2018 Local Coverage Determination (LCD) Updates

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

April 29th 2018 LCD Updates:

• L33274          Botulinum Toxins
• A55964          Botulinum toxins revision to the Part A and Part B LCD
• A55965          Botulinum Toxins Coding Guidelines
• A55509          Coding Guidelines: Noninvasive Peripheral Venous Studies
• A55529          Coding Guidelines: Noninvasive Peripheral Venous Studies
• L35698          CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing
• A55941          CYP2C19, CYP2D6, CYP2C9, and VKORC1 genetic testing revision to the Part A and Part B LCD
• A55967          Durolane® Coding and Billing Guidelines
• A52408          Filgrastim, Pegfilgrastim, Tbo-filgrastim, Filgrastim-sndz (e.g., Neupogen®, Neulasta ™, Granix ™ Zarxio™) – Related to LCD L33394
• L34002          G-CSF ( Neupogen®, Granix™,Zarxio™ )
• A55942          G-CSF (Neupogen®, Granix™, Zarxio™) revision to the Part A and Part B LCD
• L34562          Home Health Skilled Nursing Care-Teaching and Training: Alzheimer’s Disease and Behavioral Disturbances
• L34419          Homocysteine Level, Serum
• L34558          Hospice The Adult Failure To Thrive Syndrome
• A52420          Hyaluronans Intra-articular Injections of – Related to LCD L33394
• L35677          Infliximab
• L33704          Infliximab (Remicade ^TM )
• A55943          Infliximab (Remicade™) revision to the Part A and Part B LCD
• A52423          Infliximab, Infliximab-dyyb, Infliximab-abda (e.g., Remicade™, Inflectra™, Renflexis) – Related to LCD L33394
• A54386          MolDX: bioTheranostics Cancer TYPE ID® Billing and Coding Guidelines
• A54388          MolDX: bioTheranostics Cancer TYPE ID® Billing and Coding Guidelines
• A55243          MolDX: GBA Genetic Testing Billing and Coding Guidelines
• A55244          MolDX: GBA Genetic Testing Billing and Coding Guidelines
• L37305          MolDX: Oncotype DX® Genomic Prostate Score for Men with Favorable Intermediate Risk Prostate Cancer
• L37321          MolDX: Oncotype DX® Genomic Prostate Score for Men with Favorable Intermediate Risk Prostate Cancer
• L36348          MolDX: Prolaris™ Prostate Cancer Genomic Assay
• L36350          MolDX: Prolaris™ Prostate Cancer Genomic Assay
• L35008          Non-Covered Services
• L36219          Non-Covered Services
• L34399          Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
• A53497          Oral Maxillofacial Prosthesis
• A52450          Paclitaxel (e.g., Taxol®/Abraxane ™) – Related to LCD L33394
• L33443          Posterior Tibial Nerve Stimulation (PTNS) for Urinary Control
• A55426          Standard Documentation Requirements for All Claims Submitted to DME MACs
• L35076          Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT)
• L33413          Therapy and Rehabilitation Services
• A55966          Therapy and rehabilitation services revision to the Part A and Part B LCD
• A55962          Therapy services billed by physicians/nonphysician practitioners revision to the Part B LCD
• L33961          Therapy Services billed by Physicians/Nonphysician Practitioners
• L33762          Treatment of varicose veins of the lower extremity
• A55963          Treatment of varicose veins of the lower extremity revision to the Part A and Part B LCD
• L36037          Urine Drug Testing
• L33452          Virtual Colonoscopy (CT Colonography)

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.